Madoka Nagata1, Ellie D Wilson1, Kazunori Ikebukuro2

  • 1Lampe Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27599, USA.

PubMed
概括

新技术为治疗单克隆抗体 (mAbs) 提供了快速的现场监测,解决了药物动力学变异性. 这使得临床决策更快,通过床边测试实现个性化患者治疗.